Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-06-30 View official record Methodology

Covered recipient · General Payments record

COLIN B WEIGEL

Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Acute Care

NPI
1093189417
CMS profile
11202600
Location
RICHMOND, VA

General Payments · PY2023–2024

$464.41

  • Reported across 20 records
  • CMS publication 2026-06-30

Latest program year · PY2024

$368.44

15 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $368.44 15

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
ITI, Inc. $158.22 5
ABBVIE INC. $83.13 4
Gilead Sciences, Inc. $57.66 2
Indivior Inc. $54.51 3
Merck Sharp & Dohme Corporation $14.92 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2023 $95.97 5
PY2024 $368.44 15

Payment records · PY2024 (15)

Sorted by paying entity, then date · as published by CMS

Program year 2024 2023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $21.63 01/18/2024 Food and Beverage Undisputed 06/30/2026 1108391889 CMS
ABBVIE INC. $14.41 07/10/2024 Food and Beverage Undisputed 06/30/2026 1108391891 CMS
ABBVIE INC. $27.46 07/12/2024 Food and Beverage Undisputed 06/30/2026 1108391893 CMS
ABBVIE INC. $19.63 12/11/2024 Food and Beverage Undisputed 06/30/2026 1108391895 CMS
Gilead Sciences, Inc. $30.78 04/10/2024 Food and Beverage Undisputed 06/30/2026 1133657110 CMS
Gilead Sciences, Inc. $26.88 06/28/2024 Food and Beverage Undisputed 06/30/2026 1133657112 CMS
Indivior Inc. $19.60 01/25/2024 Food and Beverage Undisputed 06/30/2026 1144575577 CMS
Indivior Inc. $20.76 05/24/2024 Food and Beverage Undisputed 06/30/2026 1144575579 CMS
Indivior Inc. $14.15 10/24/2024 Food and Beverage Undisputed 06/30/2026 1144575581 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $13.84 02/22/2024 Food and Beverage Undisputed 06/30/2026 1143626168 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $16.88 03/20/2024 Food and Beverage Undisputed 06/30/2026 1143626170 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $7.82 04/04/2024 Food and Beverage Undisputed 06/30/2026 1143626172 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $9.18 04/19/2024 Food and Beverage Undisputed 06/30/2026 1143626174 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $110.50 05/02/2024 Food and Beverage Undisputed 06/30/2026 1143626176 CMS
Merck Sharp & Dohme LLC $14.92 08/22/2024 Food and Beverage Undisputed 06/30/2026 1141670494 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2023, 2024
Source files
Dataset page · Bulk file · PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.